Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6301 AL 6315

Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy

Delrieu J, Piau A, Caillaud C, Voisin T, Vellas B.

CNS Drugs. 2011 Mar;25(3):213-26. doi: 10.2165/11539810-000000000-00000.

Mania after administration of cholinesterase inhibitors in patients with dementia and comorbid bipolar disorder: two case reports

Ehrt U, Fritze F, Aarsland D.

J Clin Psychopharmacol. 2011 Apr;31(2):254-6. doi: 10.1097/JCP.0b013e31820fce90.

Safety and effectiveness of donepezil on behavioral symptoms in patients with Alzheimer disease

Carrasco MM, Agüera L, Gil P, Moríñigo A, Leon T.

Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):333-40. doi: 10.1097/WAD.0b013e318212ab7a.

[Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales]

Voigt-Radloff S, Hüll M.

Psychiatr Prax. 2011 Jul;38(5):221-31. doi: 10.1055/s-0030-1266016. Epub 2011 Mar 21.

Insight into amyloid structure using chemical probes

Reinke AA, Gestwicki JE.

Chem Biol Drug Des. 2011 Jun;77(6):399-411. doi: 10.1111/j.1747-0285.2011.01110.x. Epub 2011 Apr 26.

[Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Shioda N, Yamamoto Y, Han F, Moriguchi S, Fukunaga K.

Yakugaku Zasshi. 2011 Apr;131(4):505-11. doi: 10.1248/yakushi.131.505.

Amyloid-dependent and amyloid-independent stages of Alzheimer disease

Hyman BT.

Arch Neurol. 2011 Aug;68(8):1062-4. doi: 10.1001/archneurol.2011.70. Epub 2011 Apr 11.

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study

Barak Y, Plopski I, Tadger S, Paleacu D.

Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.

A phase II trial of huperzine A in mild to moderate Alzheimer disease

Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b.

Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial

Kennelly S, Abdullah L, Kenny RA, Mathura V, Luis CA, Mouzon B, Crawford F, Mullan M, Lawlor B.

Int J Geriatr Psychiatry. 2012 Apr;27(4):415-22. doi: 10.1002/gps.2735. Epub 2011 May 10.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.

[Support for patients with Alzheimer's disease and their caregivers by gerontechnology]

Rigaud AS, Pino M, Wu YH, DE Rotrou J, Boulay M, Seux ML, Hugonot-Diener L, DE Sant'anna M, Moulin F, LE Gouverneur G, Cristancho-Lacroix V, Lenoir H.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Mar;9(1):91-100. doi: 10.1684/pnv.2010.0248.

Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task

Miettinen PS, Pihlajamäki M, Jauhiainen AM, Tarkka IM, Gröhn H, Niskanen E, Hänninen T, Vanninen R, Soininen H.

Curr Alzheimer Res. 2011 Nov;8(7):753-64. doi: 10.2174/156720511797633241.

Galantamine and behavior in Alzheimer disease: analysis of four trials

Kavanagh S, Gaudig M, Van Baelen B, Adami M, Delgado A, Guzman C, Jedenius E, Schäuble B.

Acta Neurol Scand. 2011 Nov;124(5):302-8. doi: 10.1111/j.1600-0404.2011.01525.x. Epub 2011 May 26.

Bionanotechnologies for treatment and diagnosis of Alzheimer's disease

Moghimi SM.

Nanomedicine. 2011 Oct;7(5):515-8. doi: 10.1016/j.nano.2011.05.001. Epub 2011 May 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias